ConductScience.org, home

Trial · NCT00295646

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDAZ (Arimidex+Zoledronate)450
Overall StudySTARTEDTZ (Tamoxifen+Zoledronate)450
Overall StudySTARTEDAC (Arimidex Control)453
Overall StudySTARTEDTC (Tamoxifen Control)450
Overall StudyCOMPLETEDAZ (Arimidex+Zoledronate)415
Overall StudyCOMPLETEDTZ (Tamoxifen+Zoledronate)409
Overall StudyCOMPLETEDAC (Arimidex Control)403
Overall StudyCOMPLETEDTC (Tamoxifen Control)405
Overall StudyNOT COMPLETEDAZ (Arimidex+Zoledronate)35
Overall StudyNOT COMPLETEDTZ (Tamoxifen+Zoledronate)41
Overall StudyNOT COMPLETEDAC (Arimidex Control)50
Overall StudyNOT COMPLETEDTC (Tamoxifen Control)45

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00295646/flow